Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Geraci

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 4, 2017
Antioxidant and Osmoprotecting Activity of Taurine in Dry Eye ModelsClaudio Bucolo, Annamaria Fidilio, Chiara Bianca Maria Platania, et al.
Current Topics in Behavioral Neurosciences|April 18, 2022
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the BedsideSebastiano Alfio Torrisi, Federica Geraci, Gabriella Contarini, et al.
Frontiers in Pharmacology|October 20, 2017
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D<sub>3</sub> Receptor BlockadeSebastiano Alfio Torrisi, Salvatore Salomone, Federica Geraci, et al.
Scientific Reports|June 8, 2026
Mothers' attitudes toward exclusive breastfeeding explored using a questionnaire based on the transtheoretical model in an observational studyVincenzo Restivo, Federica Geraci, Roberta Virone, et al.
Pharmacology & Therapeutics|November 20, 2025
RNA-based drugs: current, imminent and possible therapeutic applicationsSebastiano A Torrisi, Federica Geraci, Lidia Diolosà, et al.
Drug Delivery and Translational Research|January 1, 2022
Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlatesElena Bellotti, Gabriella Contarini, Federica Geraci, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2020
Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized TreatmentsSebastiano Alfio Torrisi, Samuele Laudani, Gabriella Contarini, et al.
Frontiers in Pharmacology|July 18, 2018
Retinal Protection and Distribution of Curcumin <i>in Vitro</i> and <i>in Vivo</i>Chiara B M Platania, Annamaria Fidilio, Francesca Lazzara, et al.
International Journal of Molecular Sciences|October 5, 2017
Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative DiseasesChiara Bianca Maria Platania, Vincenzo Fisichella, Annamaria Fidilio, et al.
International Journal of Molecular Sciences|May 27, 2023
The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse BrainVeronica Rivi, Cristina Benatti, Joan M C Blom, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 4, 2017
Antioxidant and Osmoprotecting Activity of Taurine in Dry Eye ModelsClaudio Bucolo, Annamaria Fidilio, Chiara Bianca Maria Platania, et al.
Current Topics in Behavioral Neurosciences|April 18, 2022
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the BedsideSebastiano Alfio Torrisi, Federica Geraci, Gabriella Contarini, et al.
Frontiers in Pharmacology|October 20, 2017
Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D<sub>3</sub> Receptor BlockadeSebastiano Alfio Torrisi, Salvatore Salomone, Federica Geraci, et al.
Scientific Reports|June 8, 2026
Mothers' attitudes toward exclusive breastfeeding explored using a questionnaire based on the transtheoretical model in an observational studyVincenzo Restivo, Federica Geraci, Roberta Virone, et al.
Pharmacology & Therapeutics|November 20, 2025
RNA-based drugs: current, imminent and possible therapeutic applicationsSebastiano A Torrisi, Federica Geraci, Lidia Diolosà, et al.
Drug Delivery and Translational Research|January 1, 2022
Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlatesElena Bellotti, Gabriella Contarini, Federica Geraci, et al.
Pharmaceuticals (Basel, Switzerland)|November 10, 2020
Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized TreatmentsSebastiano Alfio Torrisi, Samuele Laudani, Gabriella Contarini, et al.
Frontiers in Pharmacology|July 18, 2018
Retinal Protection and Distribution of Curcumin <i>in Vitro</i> and <i>in Vivo</i>Chiara B M Platania, Annamaria Fidilio, Francesca Lazzara, et al.
International Journal of Molecular Sciences|October 5, 2017
Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative DiseasesChiara Bianca Maria Platania, Vincenzo Fisichella, Annamaria Fidilio, et al.
International Journal of Molecular Sciences|May 27, 2023
The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse BrainVeronica Rivi, Cristina Benatti, Joan M C Blom, et al.
Pageof 2